Medicine and Dentistry
Patient
100%
Inpatient
84%
Breathing
72%
Electronic Nose
71%
Asthma
67%
Exhaled Breath Condensate
64%
Metabolic Syndrome
56%
Respiratory Disease
55%
Chronic Obstructive Pulmonary Disease
55%
Metabolomics
54%
Acetylcholine
45%
Smoking
44%
Vasodilator Agent
41%
Sodium Nitroprusside
37%
Analysis
35%
Obesity
34%
Receptor
32%
Hyperinsulinemia
31%
Vasodilatation
28%
Serositis
28%
Endothelin 1
27%
Tumor Necrosis Factor
24%
Cystic Fibrosis
24%
Phenotype
23%
Vasoconstriction
22%
Drug
22%
Chemotherapeutic Agent
22%
Nose
21%
Diagnosis
21%
Sputum
21%
COVID-19
20%
Marker
20%
Child
20%
Nitric Oxide
20%
Adult
20%
Angiotensin II
17%
Primary Ciliary Dyskinesia
17%
Patient with Asthma
17%
Receptor Antagonist
16%
Development
16%
Airflow
15%
BQ-123
15%
Endothelial Dysfunction
15%
Volatile Agent
14%
Oxidative Stress
14%
Metabolite
14%
Forearm Blood Flow
14%
Blood Vessel Reactivity
14%
Infliximab
14%
Biological Product
14%
Pharmacology, Toxicology and Pharmaceutical Science
Metabolic Syndrome X
74%
Chronic Obstructive Lung Disease
66%
Drug
62%
Asthma
54%
Vasodilator Agent
52%
Insulin
46%
Obesity
42%
Stevens Johnson Syndrome
41%
Vaccine
40%
Nitroprusside Sodium
35%
Acetylcholine
33%
Hyperinsulinemia
31%
Formoterol
31%
Corticosteroid
28%
Endothelin 1
28%
Muscarinic Receptor Blocking Agent
27%
Adverse Event
27%
Radiopharmaceutical Agent
27%
angiotensin[1-7]
27%
Dupilumab
27%
Phenylephrine
27%
Nitric Oxide
19%
Case-Control Study
18%
Receptor Antagonist
17%
Eye Drops
17%
Complication
16%
Receptor
15%
Pharmacotherapy
15%
Ghrelin
13%
Glucagon-Like Peptide-1
13%
Leptin
13%
Skin Disease
13%
Noradrenalin
13%
Myocarditis
13%
Hyaline Membrane Disease
13%
Ascorbic Acid
13%
Beclometasone
12%
Fasudil
12%
Gonadorelin
12%
Luteinizing Hormone
12%
Verapamil
11%
Salmeterol
11%
Beta 2 Adrenergic Receptor Stimulating Agent
10%
Incidence
10%
Calcium
10%
Absence
10%
Glucose
10%
Endothelin
9%
Agents Acting on the Eye
9%
Biological Product
9%
Biochemistry, Genetics and Molecular Biology
Breathing
92%
Metabolomics
37%
Gonadotropin-Releasing Hormone
26%
Endothelin 1
19%
Phenotype
19%
Primary Ciliary Dyskinesia
17%
Nuclear Magnetic Resonance Spectroscopy
17%
Magnetism
16%
Vasoconstriction
15%
Cystic Fibrosis
15%
Corticosteroid
13%
Rituximab
13%
Kisspeptin
13%
Leukotriene
13%
Obestatin
13%
Gonadotropin-Releasing Hormone
13%
Normal Human
12%
Vasodilatation
12%
Human
11%
Nitric Oxide
11%
GnRH Neuron
10%
Proteomics
9%
Angiotensin
9%
Action Potential
8%
Secretion (Process)
7%
Bendamustine
7%
Liquid
7%
Cyclic Adenosine Monophosphate
7%
Time
6%
Classification
6%
Development
6%
Insulin
5%
Proteomics
5%
G Protein
5%
Medication Compliance
5%
Regulatory Mechanism
5%
Liquid Chromatography Mass Spectrometry
5%
Tandem Mass Spectrometry
5%
Hormone Release
5%
BQ-123
5%
Pertussis Toxin
5%
